| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |